ArticleBMC veterinary research2025
Influence of pulsed electromagnetic field (PEMF) therapy on osteoarthritis in dogs.
Article in BMC veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Bedinvetmab, alone or in combination with photobiomodulation and pulsed electromagnetic field therapy, on pain and quality of life in dogs with hip osteoarthritis.Veterinary research communications · 2026Article
- Variations in the management of canine osteoarthritis: a cross-sectional survey of veterinary practices.Frontiers in veterinary science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis randomized, double-blind, placebo-controlled clinical trial investigated the therapeutic efficacy of pulsed electromagnetic field (PEMF) therapy in dogs diagnosed with chronic osteoarthritis (OA).
methodsTwenty-one dogs with radiographically confirmed OA in at least one limb were randomized into treatment (n = 10) and placebo (n = 11) groups. PEMF therapy was administered over six weeks. Gait symmetry indices for peak vertical force and vertical impulse were assessed using kinetic analysis at baseline (Day 0), mid-treatment (Day 21), and post-treatment (Day 42). Lameness and pain scores, additional treatments, and dropout rates were recorded. Owners completed the Liverpool Osteoarthritis in Dogs (LOAD) questionnaire at each time point. An Overall Treatment Effectiveness (OTE) score was computed based on objective and subjective outcomes.
resultsPEMF-treated dogs exhibited significant improvements in gait symmetry by Day 42 (p = 0.030). LOAD scores declined steadily in the treatment group, although no statistically significant differences were observed between groups. This trend may suggest a potential reduction in pain and improvement in mobility. No significant between-group differences were found for the OTE score.
conclusionPEMF therapy appears to be a safe, non-invasive, and potentially effective adjunctive or stand-alone modality for the management of pain and mobility impairment associated with osteoarthritis in dogs. Further research is warranted to confirm long-term efficacy and optimize treatment protocols.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.